A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia
This study has been completed.
Study NCT00008840
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: January 18, 2001
Last Updated: November 9, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
